Clinical Trials

Overview

Ocera is committed to providing information to patients and health care providers on ongoing trials and communicating the results of these trials in a timely manner.

OCR-002:

Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding

 

 

AST-120:

AST014: Safety and efficacy of AST-120 in patients with non-constipating irritable bowel syndrome

AST015: Safety and efficacy of AST-120 compared to lactulose in patients with hepatic encephalopathy

The ASTUTE Trial: AST-MHE201: AST-120 Used to treat mild hepatic encephalopathy

$('.clickable').fitted();